COMMODORE CAPITAL
Commodore Capital is invested in the early stages of a major innovation cycle in biopharmaceuticals.
COMMODORE CAPITAL
Social Links:
Founded:
2019-01-01
Status:
Active
Contact:
(917) 970-1730
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Office 365 Mail GoDaddy DNS Typekit
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-13 | Arkive | Commodore Capital investment in Seed Round - Arkive | 9.7 M USD |
| 2022-05-16 | Celcuity | Commodore Capital investment in Post-IPO Equity - Celcuity | 100 M USD |
| 2022-01-16 | Third Harmonic Bio | Commodore Capital investment in Series B - Third Harmonic Bio | 105 M USD |
| 2021-11-02 | Shoreline Biosciences | Commodore Capital investment in Series B - Shoreline Biosciences | 140 M USD |
| 2021-07-13 | Nimbus Therapeutics | Commodore Capital investment in Venture Round - Nimbus Therapeutics | 105 M USD |
| 2021-03-01 | Satsuma Pharmaceuticals | Commodore Capital investment in Post-IPO Equity - Satsuma Pharmaceuticals | 80 M USD |
| 2021-02-07 | Shoreline Biosciences | Commodore Capital investment in Series A - Shoreline Biosciences | 43 M USD |
| 2020-08-25 | Kronos Bio | Commodore Capital investment in Private Equity Round - Kronos Bio | 155 M USD |
| 2020-07-06 | Cogent Biosciences | Commodore Capital investment in Post-IPO Equity - Cogent Biosciences | 104.4 M USD |
| 2020-06-16 | C4 Therapeutics | Commodore Capital investment in Series B - C4 Therapeutics | N/A |